Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in ...
11hon MSN
Inside Billy Gardell's weight loss journey: All about the comedian’s life-saving transformation
The Mike & Molly star has been on a lifelong journey with his weight ever since he was young, when he ate as a way to cope ...
A woman allegedly posed as an heiress and scammed nearly $30 million from banks and institutions in Los Angeles and Orange counties, according to authorities.
The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce, Eli Lilly said.
A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...
Weight loss drugs like Ozempic have ‘little’ effect on obesity-linked cancers, researchers find - Some of the nation’s ...
We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Structure Therapeutics Inc. (NASDAQ:GPCR) ...
RBC Capital Markets upgraded Wave Life Sciences (WAV) to outperform from sector perform, lauding the recent phase 1 results ...
Zacks Investment Research on MSN
Hims & Hers plunges 29.1% in 6 months: Time to hold the stock or sell?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its ...
Investor's Business Daily on MSN
In the 'uber bull' biotech market, is Structure the next Metsera?
In a post-Metsera world, Structure Therapeutics could be the next big takeover candidate, analysts said Tuesday.
The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity ...
Money Talks News on MSN
Trump's $245 drug deal: States say it doesn't solve their budget crisis
Trump's deal to reduce weight-loss drug prices to $245 monthly may not help cash-strapped states already paying similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results